FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

327338004: Product containing precisely goserelin (as goserelin acetate) 10.8 milligram/1 each prolonged-release subcutaneous implant (clinical drug)


Status: current, Defined. Date: 31-Jul 2019. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3764401014 Product containing precisely goserelin (as goserelin acetate) 10.8 milligram/1 each prolonged-release subcutaneous implant (clinical drug) en Fully specified name Active Case insensitive SNOMED CT core
3764402019 Goserelin (as goserelin acetate) 10.8 mg prolonged-release subcutaneous implant en Synonym Active Case insensitive SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Goserelin (as goserelin acetate) 10.8 mg prolonged-release subcutaneous implant Has precise active ingredient Goserelin acetate true Inferred relationship Some 1
Goserelin (as goserelin acetate) 10.8 mg prolonged-release subcutaneous implant Has unit of presentation Implant true Inferred relationship Some
Goserelin (as goserelin acetate) 10.8 mg prolonged-release subcutaneous implant Count of base of active ingredient 1 false Inferred relationship Some
Goserelin (as goserelin acetate) 10.8 mg prolonged-release subcutaneous implant Has BoSS Goserelin true Inferred relationship Some 1
Goserelin (as goserelin acetate) 10.8 mg prolonged-release subcutaneous implant Has presentation strength numerator value 10.8 false Inferred relationship Some 1
Goserelin (as goserelin acetate) 10.8 mg prolonged-release subcutaneous implant Is a Carboxylic acid and/or carboxylic acid derivative-containing product false Inferred relationship Some
Goserelin (as goserelin acetate) 10.8 mg prolonged-release subcutaneous implant Has presentation strength denominator unit Implant true Inferred relationship Some 1
Goserelin (as goserelin acetate) 10.8 mg prolonged-release subcutaneous implant Is a Acetic acid and/or acetic acid derivative-containing product false Inferred relationship Some
Goserelin (as goserelin acetate) 10.8 mg prolonged-release subcutaneous implant Has presentation strength numerator unit mg true Inferred relationship Some 1
Goserelin (as goserelin acetate) 10.8 mg prolonged-release subcutaneous implant Has presentation strength denominator value 1 false Inferred relationship Some 1
Goserelin (as goserelin acetate) 10.8 mg prolonged-release subcutaneous implant Is a Goserelin only product in subcutaneous dose form false Inferred relationship Some
Goserelin (as goserelin acetate) 10.8 mg prolonged-release subcutaneous implant Is a Goserelin only product in parenteral dose form true Inferred relationship Some
Goserelin (as goserelin acetate) 10.8 mg prolonged-release subcutaneous implant Is a Goserelin-containing product false Inferred relationship Some
Goserelin (as goserelin acetate) 10.8 mg prolonged-release subcutaneous implant Has active ingredient Goserelin false Inferred relationship Some
Goserelin (as goserelin acetate) 10.8 mg prolonged-release subcutaneous implant Has active ingredient Synthetic hormone agent false Inferred relationship Some
Goserelin (as goserelin acetate) 10.8 mg prolonged-release subcutaneous implant Has active ingredient Gonadotropin false Inferred relationship Some
Goserelin (as goserelin acetate) 10.8 mg prolonged-release subcutaneous implant Has manufactured dose form Implant false Inferred relationship Some
Goserelin (as goserelin acetate) 10.8 mg prolonged-release subcutaneous implant Has manufactured dose form Prolonged-release subcutaneous implant true Inferred relationship Some
Goserelin (as goserelin acetate) 10.8 mg prolonged-release subcutaneous implant Is a TEMPORARY parent for CDs that are not updated false Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start